Related Experiment Video
Updated: Jan 8, 2026

07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
4.6K
Unfermented High-Fiber Rye Crispbread Increases Plasma HDL and Reduces Hepatic Lipids Compared to Refined Wheat in
Fidèle Almasri1, Eleonora Aimaretti2, Nadine Sus1
1Department of Food Biofunctionality, Institute of Nutritional Sciences, University of Hohenheim, Stuttgart, Germany.
Molecular Nutrition & Food Research
|December 13, 2025
Summary
Whole-grain rye crispbread, particularly unfermented, improved lipid metabolism in rats by increasing HDL-cholesterol and reducing liver fats. This suggests potential benefits for managing cholesterol levels.
Area of Science:
- Nutrition Science
- Gastroenterology
- Metabolic Health
Background:
- Fiber-rich rye foods show potential for weight management in humans compared to refined wheat.
- Mechanisms underlying rye's effects on body weight and metabolism require further investigation.
Purpose of the Study:
- To compare the effects of whole grain fermented and unfermented rye crispbread with refined wheat crispbread on body weight and lipid metabolism in rats.
- To explore impacts on adiposity, appetite biomarkers, glucose homeostasis, and colon health.
Main Methods:
- Sprague Dawley rats (n=54) were fed high-fat diets for 16 weeks, then randomized to control or diets with refined wheat, fermented rye, or unfermented rye crispbread for 8 weeks.
- Exploratory outcomes included body weight, adiposity, lipid profiles, glucose homeostasis, and colon parameters.
Main Results:
- High-fat diet increased energy intake, adiposity, leptin, and hepatic triacylglycerols.
- Unfermented rye crispbread increased plasma HDL-cholesterol and reduced hepatic triacylglycerols and cholesterol compared to refined wheat.
- No significant differences were found between fermented and unfermented rye, nor on obesity or glycemic control.
Conclusions:
- Unfermented whole-grain rye crispbread demonstrated favorable lipid-modulating effects in rats.
- Rye crispbread may offer benefits for lipid metabolism, independent of effects on body weight or glycemic control.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Lipid Digestion
98.5K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.5K

